Biogen Inc

Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry

Biotech Sector Turns Red-Hot on Alzheimer’s Treatment News

Big Pharma and The Need for Speed

Voyager Therapeutics Names Alfred Sandrock as CEO, Former Biogen R&D Head

Yumanity Therapeutics To Cut 60% of Staff, Explore Strategic Options